Browse News Stories
11 to 20 of 76 stories
view headlines only
-
Vioxx Trial Data Shows Early Cardiovascular Risk
November 23, 2009 Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, ... > full story -
Discovery In Colon Cancer Prevention
May 18, 2009 A new study finds that individuals who have low expression of the "Celebrex gene," 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon ... > full story -
Potential Lung Disease Biomarkers Yield Clues To COX-2 Inhibitor Side Effects
April 29, 2009 In searching for a simple way to identify individuals with smoking-related lung injury, scientists at have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 ... > full story -
Prostaglandin Receptor Key To Atherosclerosis Development
December 15, 2008 Atherosclerosis -- a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall -- is the underlying cause of heart attacks and strokes. Researchers have now ... > full story -
Potential New Drug Targets Against Hormone-Dependent Breast Cancer Identified
February 28, 2008 The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease. The finding ... > full story -
Popular Arthritis Drug May Disrupt Heart Rhythm, New Research Finds
January 24, 2008 Celebrex, a popular arthritis drug that blocks pain by inhibiting an enzyme known as COX-2, has been shown in laboratory studies to induce arrhythmia, or irregular beating of the heart, via a novel ... > full story -
Celecoxib Can Adversely Affect Heart Rhythm, Study Suggests
January 14, 2008 COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another ... > full story -
Vioxx Side-Effects: Possible Explanation
August 27, 2007 Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. Scientists may now have figured out how these drugs trigger these ... > full story -
Celecoxib Helps Prevent Restenosis And Appears Safe
August 18, 2007 Adjunctive use of the COX-2 inhibitor celcoxib after stent implantation in patients with coronary artery disease appears safe and can reduce the need for revascularisation of the target lesion, ... > full story -
Researcher Lays Out Benefits Of Aspirin To Prevent Colon Cancer
May 23, 2007 A colon cancer researcher has laid out in a recent article how he thinks medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk ... > full story
Search ScienceDaily
Number of stories in archives: 140,690

